Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules
Clinical trial NCT00652743 · COMPLETED
Trial details
- NCT number
- NCT00652743
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-23
- Primary completion
- 2011-06-08
- Enrollment
- 845
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.